Cvrx Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Cvrx Inc inventory turnover ratio, the Cvrx Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 0.61 in the third quarter 2026, yet the ratio remained below the average, as CVRX's market remain challenging.Average inventory processing period, for the Cvrx Inc in Sep 30 2026 quarter, has decreased to 598 days, compare to 640 days, in the Jun 30 2026 quarter.

Within Healthcare sector 350 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. 1741.

CVRX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cvrx Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CVRX Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	19.61 %	11.16 %	6.26 %	0.81 %	-4.19 %
Y / Y Cost of Sales Growth	83.4 %	-0.95 %	-50 %	-25 %	-50 %
Inventory Turnover Ratio (TTM)	0.61	0.57	0.59	0.68	0.77
CVRX's Total Ranking	# 1741	# 1741	# 481	# 1175	#
Average inventory processing period	599	641	622	536	475
Seq. Inventory Growth	4.61 %	5.04 %	1.62 %	7.12 %	-2.78 %
Seq. Cost of Sales Growth	-7.42 %	98.1 %	-66.67 %	200 %	-50 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 155
Healthcare Sector	# 351
Overall Market	# 1741

Inventory Turnover Ratio Statistics
High	Average	Low
0.87	0.67	0.51
(Jun 30 2022)		(Jun 30 2024)

CVRX Company Profile >> Back to CVRX Efficiency Comparisons >> Compare CVRX Inventory Turnover Ratio to its Competitors

Financial Statements
Cvrx Inc 's Inventories	$ 14 Millions	Visit CVRX's Balance sheet
Cvrx Inc 's Cost of Revenues TTM	$ 8 Millions	Visit CVRX's Income Statement
What are CVRX's Sales?		Visit CVRX's Sales by Segment

Other Inventory Turnover Ratios
Cvrx Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CVRX's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CVRX's Competitors
Inventory Turnover Ratio for CVRX's Suppliers
Inventory Turnover Ratio for CVRX's Customers

You may also want to know
CVRX's Sales Growth Rates	CVRX's Pe Price to earnings ratio	CVRX's Receivables Turnover Ratio	CVRX's Stock Quote
CVRX's Net Income Growth Rates	CVRX's Ps Price to Sales ratio	CVRX's Sales per Employee	CVRX's Asset Turnover Ratio
CVRX's Net Margin	CVRX's Pb Price to Book ratio	CVRX's Financial Strength Ratios	CVRX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Sanuwave Health Inc	1.54	$ 9.845 Millions	$ 6 Millions
Humacyte Inc	1.53	$ 13.780 Millions	$ 9 Millions
Waters Corporation	1.51	$ 1,797.864 Millions	$ 1,192 Millions
Axogen inc	1.49	$ 68.923 Millions	$ 46 Millions
Aurinia Pharmaceuticals Inc	1.29	$ 30.165 Millions	$ 23 Millions
Hyperfine Inc	1.28	$ 8.502 Millions	$ 7 Millions
Pulmonx Corporation	1.28	$ 20.450 Millions	$ 16 Millions
Alphatec Holdings Inc	1.27	$ 241.341 Millions	$ 189 Millions
Si bone inc	1.25	$ 46.999 Millions	$ 38 Millions
Bridgebio Pharma Inc	1.24	$ 53.542 Millions	$ 43 Millions
Biogen Inc	1.23	$ 2,681.800 Millions	$ 2,181 Millions
Lensar Inc	1.22	$ 28.813 Millions	$ 24 Millions
Kiniksa Pharmaceuticals International Plc	1.21	$ 93.072 Millions	$ 77 Millions
Mannkind Corporation	1.16	$ 51.332 Millions	$ 44 Millions
Rhythm Pharmaceuticals Inc	1.14	$ 33.056 Millions	$ 29 Millions
Penumbra Inc	1.13	$ 499.548 Millions	$ 443 Millions
Teleflex Incorporated	1.12	$ 427.166 Millions	$ 380 Millions
Acadia Pharmaceuticals Inc	1.12	$ 114.422 Millions	$ 102 Millions
Corcept Therapeutics Inc	1.11	$ 14.097 Millions	$ 13 Millions
Alkermes Plc	1.10	$ 300.119 Millions	$ 273 Millions
Neurocrine Biosciences Inc	1.07	$ 81.200 Millions	$ 76 Millions
Emergent Biosolutions Inc	1.07	$ 334.800 Millions	$ 314 Millions
Seer Inc	1.03	$ 7.698 Millions	$ 7 Millions
Vertex Pharmaceuticals Inc	1.00	$ 1,874.100 Millions	$ 1,866 Millions
Beone Medicines Ltd	0.99	$ 701.426 Millions	$ 708 Millions
Amarin Corp Plcuk	0.92	$ 104.502 Millions	$ 113 Millions
Eli Lilly And Company	0.89	$ 14,149.700 Millions	$ 15,815 Millions
Cerus Corporation	0.87	$ 54.000 Millions	$ 62 Millions
Maxcyte inc	0.86	$ 6.538 Millions	$ 8 Millions
Co diagnostics Inc	0.82	$ 0.689 Millions	$ 1 Millions

Date modified: 2026-11-06T12:56:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.